Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00753402 · ClinicalTrials.gov registry record · Phase 1
The Effects of Epinephrine in Endotoxemia in Normal Volunteers
A Phase 1 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 1
- Development phase
- 37
- Enrollment target
NCT00753402 is a Phase 1 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 37 participants.
The verdict
NCT00753402, a Phase 1 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
Epinephrine (adrenaline) is a substance produced by the body (in the adrenal gland) in response to stress such as infection or injury. Endotoxin is a man- made substance, which causes the body to "mimic" sickness (fever, chills, and achiness) for a few hours. This study is designed to give epinephrine before and/or after endotoxin to determine if this medication can prevent or relieve any of the symptoms caused by endotoxin.
Interventions
- BIOLOGICAL Endotoxin, Lipopolysaccharide, LPS
- BIOLOGICAL Endotoxin, Epinephrine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2012-02 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00753402
The ClinicalTrials.gov registry entry for NCT00753402 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endotoxin, Lipopolysaccharide, LPS is the first listed.
NCT00753402 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00753402 about?
NCT00753402 is a clinical study titled "The Effects of Epinephrine in Endotoxemia in Normal Volunteers". Epinephrine (adrenaline) is a substance produced by the body (in the adrenal gland) in response to stress such as infection or injury. Endotoxin is a man- made substance, which causes the body to "mimic" sickness (fever, chills, and achiness) for a few hours. This study is designed to give epinephri...
What is the current status of trial NCT00753402?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 37 participants. The study started on 2012-02. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00753402?
The interventions under investigation include: Endotoxin, Lipopolysaccharide, LPS (BIOLOGICAL), Endotoxin, Epinephrine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00753402?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.